[Form 4] BROADRIDGE FINANCIAL SOLUTIONS, INC. Insider Trading Activity

Rhea-AI Filing Summary

Broadridge Financial Solutions director equity awards reported

A director of Broadridge Financial Solutions, Inc. (BR) reported receiving 459 shares of common stock on 11/13/2025 at a stated price of $0.0000. The filing explains this reflects a grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan, which vest in full upon grant and will be settled in common shares when the director leaves board service.

The director also received a stock option covering 1,758 shares of Broadridge common stock at an exercise price of $225.61, which vests immediately and expires on 11/13/2035. Following these transactions, the director reports 20,977 shares held directly and additional indirect holdings through BOMAR II LLC and two revocable trusts.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Duelks Robert N

(Last) (First) (Middle)

5 DAKOTA DRIVE

(Street)

LAKE SUCCESS NY 11042

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
BROADRIDGE FINANCIAL SOLUTIONS, INC. [ BR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/13/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/13/2025		A		459	A	$0.0000(1)	20,977	D
Common Stock								4,960	I	BOMAR II LLC
Common Stock								17,000	I	Mary E. Duelks 2007 Revocable Trust
Common Stock								8,853	I	Robert N. Duelks 2007 Revocable Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$225.61	11/13/2025		A		1,758		11/13/2025(2)	11/13/2035	Common Stock	1,758	$0.0000	1,758	D

Explanation of Responses:

1. The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan and represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

2. Stock options vest immediately upon grant.

	Maria Allen, Power of Attorney	11/17/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Broadridge (BR) report in this Form 4?

The Form 4 reports that a director of Broadridge Financial Solutions, Inc. (BR) received 459 shares of common stock on 11/13/2025, reflecting a grant of Deferred Stock Units under the company’s 2018 Omnibus Award Plan, and a stock option for 1,758 shares at an exercise price of $225.61.

How do the Deferred Stock Units granted to the Broadridge director work?

The filing states that the reported transaction reflects a grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan, representing a like number of shares of common stock. These units vest in full upon grant and will be settled in shares of Broadridge common stock upon the director's separation from service with the company.

What are the terms of the stock option granted to the Broadridge director?

The director received a stock option (right to buy) covering 1,758 shares of Broadridge common stock with an exercise price of $225.61 per share. The filing notes that these stock options vest immediately upon grant and have an expiration date of 11/13/2035.

How many Broadridge shares does the director own after the reported transactions?

After the reported transactions, the director reports 20,977 shares of Broadridge common stock held directly. In addition, the director reports 4,960 shares held indirectly through BOMAR II LLC, 17,000 shares held indirectly through the Mary E. Duelks 2007 Revocable Trust, and 8,853 shares held indirectly through the Robert N. Duelks 2007 Revocable Trust.

What is the reporting person’s relationship to Broadridge (BR)?

The filing identifies the reporting person’s relationship to Broadridge Financial Solutions, Inc. as a Director. The form indicates it is filed by one reporting person, not a joint or group filing.

Was this Broadridge Form 4 filed under a Rule 10b5-1 trading plan?

The form includes a checkbox to indicate if a transaction was made under a Rule 10b5-1(c) contract, instruction or written plan. The excerpt does not show that this box is checked, and the transactions are described as equity awards (Deferred Stock Units and stock options) rather than open-market trades.